NGNE – neurogene inc. (US:NASDAQ)
Stock Stats
News
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neurogene (NGNE) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $200.00 price target on the stock.
Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome [Yahoo! Finance]
Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome
Form 4 Neurogene Inc. For: Feb 27 Filed by: Cvijic Christine Mikail
Form 144 Neurogene Inc. Filed by: Cvijic Christine Mikail
Form 8-K Neurogene Inc. For: Feb 26
Form 4 Neurogene Inc. For: Feb 20 Filed by: Cobb Stuart
Form 4 Neurogene Inc. For: Feb 20 Filed by: Cvijic Christine Mikail
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.